WO2002042422A3 - Interactions moleculaires dans des cellules hematopoietiques - Google Patents
Interactions moleculaires dans des cellules hematopoietiques Download PDFInfo
- Publication number
- WO2002042422A3 WO2002042422A3 PCT/US2001/044138 US0144138W WO0242422A3 WO 2002042422 A3 WO2002042422 A3 WO 2002042422A3 US 0144138 W US0144138 W US 0144138W WO 0242422 A3 WO0242422 A3 WO 0242422A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hematopoietic cells
- molecular interactions
- cells
- reagents
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01987086A EP1387692A4 (fr) | 2000-11-11 | 2001-11-09 | Interactions moleculaires dans des cellules hematopoietiques |
AU2002239336A AU2002239336A1 (en) | 2000-11-10 | 2001-11-09 | Molecular interactions in hematopoietic cells |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71005900A | 2000-11-10 | 2000-11-10 | |
US09/710,059 | 2000-11-10 | ||
US72206900A | 2000-11-24 | 2000-11-24 | |
US72191500A | 2000-11-24 | 2000-11-24 | |
US09/721,915 | 2000-11-24 | ||
US09/722,069 | 2000-11-24 | ||
US72455300A | 2000-11-28 | 2000-11-28 | |
US09/724,553 | 2000-11-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002042422A2 WO2002042422A2 (fr) | 2002-05-30 |
WO2002042422A3 true WO2002042422A3 (fr) | 2003-08-14 |
Family
ID=27505517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/044138 WO2002042422A2 (fr) | 2000-11-10 | 2001-11-09 | Interactions moleculaires dans des cellules hematopoietiques |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1387692A4 (fr) |
AU (1) | AU2002239336A1 (fr) |
WO (1) | WO2002042422A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6942981B1 (en) | 1999-05-14 | 2005-09-13 | Arbor Vita Corporation | Method of determining interactions with PDZ-domain polypeptides |
WO2004109288A1 (fr) * | 2003-06-06 | 2004-12-16 | Astrazeneca Ab | Methode de diagnostic |
WO2005097828A2 (fr) * | 2004-04-01 | 2005-10-20 | Board Of Regents, The University Of Texas System | Peptides de cav2.2 inhibant la douleur |
EP2374469A3 (fr) * | 2004-12-21 | 2012-01-25 | MUSC Foundation For Research Development | Compositions et procédés pour la promotion de la cicatrisation de plaies et de la régénération de tissus |
AU2012202117B2 (en) * | 2004-12-21 | 2014-06-26 | Musc Foundation For Research Development | Compositions and methods for promoting wound healing and tissue regeneration |
US9408381B2 (en) | 2004-12-21 | 2016-08-09 | Musc Foundation For Research Development | Alpha Connexin c-Terminal (ACT) peptides for use in transplant |
US8633160B2 (en) | 2005-12-30 | 2014-01-21 | Nono Inc. | Small molecule inhibitors of PDZ interactions |
WO2012048276A2 (fr) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Procédés et systèmes configurables pour la culture et la récolte de cellules dans un système de bioréacteur à fibres creuses |
SG11201405359YA (en) | 2012-03-01 | 2014-09-26 | Firststring Res Inc | Topical gels containing alpha connexin c-terminal (act) peptides |
WO2015073918A1 (fr) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expansion de cellules dans un bioréacteur |
CN106232800B (zh) | 2014-03-25 | 2020-07-03 | 泰尔茂比司特公司 | 介质的被动替代 |
JP6683686B2 (ja) | 2014-08-22 | 2020-04-22 | オークランド ユニサービシーズ リミティド | チャネル調節剤 |
CN106715676A (zh) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | 按计划供养 |
WO2017004592A1 (fr) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Croissance cellulaire à l'aide de stimuli mécaniques |
WO2017205667A1 (fr) | 2016-05-25 | 2017-11-30 | Terumo Bct, Inc. | Expansion cellulaire |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
CN110612344B (zh) | 2017-03-31 | 2023-09-12 | 泰尔茂比司特公司 | 细胞扩增 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0670040A1 (fr) * | 1993-09-22 | 1995-09-06 | Baxter Diagnostics Inc. | Immobilisation de proteines chimiquement reticulees sur des supports solides |
-
2001
- 2001-11-09 EP EP01987086A patent/EP1387692A4/fr not_active Withdrawn
- 2001-11-09 AU AU2002239336A patent/AU2002239336A1/en not_active Abandoned
- 2001-11-09 WO PCT/US2001/044138 patent/WO2002042422A2/fr not_active Application Discontinuation
Non-Patent Citations (5)
Title |
---|
FAULKNER G. ET AL.: "A new Z-band alternatively spliced PDZ-motif protein", THE JOURNAL OF CELL BIOLOGY, vol. 146, no. 2, 26 July 1999 (1999-07-26), pages 465 - 475, XP002958709 * |
See also references of EP1387692A4 * |
VALLENIUS T. ET AL.: "CLP-36 PDZ-LIM protein associates with nonmuscle alpha-actinin-1 and alpha-actinin-4", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 15, 14 April 2000 (2000-04-14), pages 11100 - 11105, XP002958708 * |
WECHSLER A. ET AL.: "Brain spectrin binding to the NMDA receptor is regulated by phosphorylation, calcium and calmodulin", THE EMBO JOURNAL, vol. 17, no. 14, 1998, pages 3931 - 3939, XP002958710 * |
XIA H. ET AL.: "Actinin-associated LIM protein: identification of a domain interaction between PDZ and spectrin-like repeat motifs", THE JOURNAL OF CELL BIOLOGY, vol. 139, no. 2, October 1997 (1997-10-01), pages 507 - 515, XP002958711 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002042422A2 (fr) | 2002-05-30 |
EP1387692A4 (fr) | 2004-07-21 |
EP1387692A2 (fr) | 2004-02-11 |
AU2002239336A1 (en) | 2002-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000069896A3 (fr) | Interactions moleculaires dans les cellules hematopoietiques | |
WO2002042422A3 (fr) | Interactions moleculaires dans des cellules hematopoietiques | |
WO2003014303A3 (fr) | Interactions moleculaires dans les cellules | |
AU7097400A (en) | Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof | |
WO2001018248A3 (fr) | Signalisation de detection de quorum chez des bacteries | |
EP1462525A4 (fr) | Systeme d'expression d'arnsi et procede de production de cellule knockdown a gene fonctionnel ou analogue utilisant ce systeme | |
WO2003050260A3 (fr) | Fusions de genes exprimees par la streptavidine et leurs procedes d'utilisation | |
WO1999020747A3 (fr) | NOUVELLE KINASE HUMAINE POINT DE CONTROLE, hCDS1, COMPOSITIONS ET METHODES ASSOCIEES | |
WO2004013290A3 (fr) | Compositions et procedes applicables a la biologie moleculaire | |
WO2002062957A3 (fr) | Compositions et methodes de biologie moleculaire | |
WO2001072822A3 (fr) | Genes impliques dans les maladies inflammatoires de l"intestin et leur utilisation | |
AU1728001A (en) | Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample | |
AU2001238212A1 (en) | Modified fluorescent proteins | |
WO2001049721A3 (fr) | Nouveaux genes bacteriens et proteines qui sont essentielles pour la viabilite cellulaire et leurs utilisations | |
WO2002031512A3 (fr) | Interactions moleculaires dans des cellules hematopoietiques | |
WO2000050607A3 (fr) | Proteine de liaison a l'antigene du syndrome de goodpasture | |
DE69634077D1 (de) | Haemophilus adhäsionsproteinen | |
MX9806041A (es) | Proteina purificada sr-p70. | |
WO2000069898A8 (fr) | Interactions moleculaires dans les reactions allergiques | |
WO2003095971A3 (fr) | Acides nucleiques et polypeptides a domaines sh3 multiples (posh) et methodes associees | |
AU2002365269A1 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
WO2001066752A3 (fr) | Genes specifiques de la reproduction | |
WO2001059120A3 (fr) | Molecules de type il-17 et utilisation de ces dernieres | |
AU2001256232A1 (en) | Genes isolated from dendritic cells, gene products and methods employing the same | |
AU3556800A (en) | Expression of dna or proteins in (c. elegans) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001987086 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001987086 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |